Cite
MLA Citation
Aaron T. Gerds et al.. “Corrigendum to "Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib" [Leukemia Res. 79 (2019) 38–44].” Leukemia research, vol. 81, 2019, pp. 105–. http://access.bl.uk/ark:/81055/vdc_100083742518.0x00005c